Xuefang Zhang
Overview
Explore the profile of Xuefang Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li R, Zhang X, Liu X, Gu Z, He J, Dong Y, et al.
JACC Asia
. 2025 Feb;
5(1):143-157.
PMID: 39896250
Background: As a competitive nonthermal energy technique used in atrial fibrillation (AF), the effectiveness and safety of pulsed field ablation (PFA) has remained uncertain. Objectives: The authors meta-analysis aimed to...
2.
Li S, Du J, Wang X, Huang Y, Huang Y, Chang Z, et al.
Eur Spine J
. 2025 Jan;
34(3):1004-1017.
PMID: 39820738
Background: Posterior laminectomy is a standard treatment for thoracic ossification of the ligamentum flavum (TOLF), but it often leads to neurological deterioration during surgery. This study aimed to reduce iatrogenic...
3.
Wang Z, Gao H, Wang X, Grzegorzek M, Li J, Sun H, et al.
BMC Womens Health
. 2024 Nov;
24(1):602.
PMID: 39529020
No abstract available.
4.
Zhang X, Gao X, Zhang X, Yao X, Kang X
Int J Nanomedicine
. 2024 Oct;
19:10661-10684.
PMID: 39464675
Hydrogels are multifunctional platforms. Through reasonable structure and function design, they use material engineering to adjust their physical and chemical properties, such as pore size, microstructure, degradability, stimulus-response characteristics, etc....
5.
Wu D, Liang H, Kaisaier W, Li J, Sun G, Dong Y, et al.
J Thromb Thrombolysis
. 2024 Jul;
57(7):1256-1267.
PMID: 39080118
Studies have demonstrated the beneficial effects of non-vitamin K antagonist oral anticoagulants (NOACs) for the treatment of atrial fibrillation and venous thromboembolism (VTE). The impact of NOACs on chronic thromboembolic...
6.
Cui H, Ma Y, Han S, Zhang X, Fu W, Yang S, et al.
Leuk Res
. 2024 Jul;
144:107550.
PMID: 39079325
Objective: To investigate the relationship between the treatment of acute promyelocytic leukemia (APL) with arsenic trioxide (ATO) and glycolysis, as well as its underlying molecular mechanism. Methods: The GEO database...
7.
Wang Z, Gao H, Wang X, Grzegorzek M, Li J, Sun H, et al.
BMC Womens Health
. 2024 Jul;
24(1):425.
PMID: 39060940
Purpose: To build an Mult-Task Learning (MTL) based Artificial Intelligence(AI) model that can simultaneously predict clinical stage, histology, grade and LNM for cervical cancer before surgery. Methods: This retrospective and...
8.
Abudouaini H, Zhang X, Dai Y, Meng Y, Lu Q, Ren Q, et al.
Biochem Pharmacol
. 2024 Jul;
227:116453.
PMID: 39059773
Spinal echinococcosis is one of the most overlooked zoonotic parasitic diseases worldwide. There is currently no safe and effective treatment to eradicate it, and research based on the physiological-metabolic signature...
9.
Zhang X, Zhang Y, Sun G, Li Z, Tan W, Fan Y, et al.
Int J Cardiol
. 2024 Jul;
413:132359.
PMID: 39004352
Background: Studies have revealed the beneficial effects of sodium-glucose co-transporter 2 inhibitors (SGLT2i) for the treatment of heart failure (HF) regardless of the presence of diabetes. Besides, SGLT2i can decrease...
10.
Zhang X, Sun G, Li Z, Gao W, Tan W, Liu J, et al.
J Cardiovasc Pharmacol
. 2024 Jul;
84(1):18-25.
PMID: 38968565
Recent studies have revealed the benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in heart failure patients. However, their effects on acute myocardial infarction (AMI) remain uncertain. Therefore, we conducted this...